Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats
PLOS Pathogens · 26.12.2024 · 20 (12) · e1012763
DOI: 10.1371/journal.ppat.1012763 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 26.12.2024. Verfasst von Nelly S C Mak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom. Hauptthemen laut MEDLINE: Alternative Splicing, Chiroptera, Membrane Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Medical Research Council, University of Edinburgh and Leiden University Medical Center One Health PhD Studentship, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Species-specific interferon responses are shaped by the virus-host arms race. The human interferon-induced transmembrane protein (IFITM) family consists of three antiviral IFITM genes that arose by gene duplication. These genes restrict virus entry and are key players in antiviral interferon responses. The unique IFITM repertoires in different species influence their resistance to viral infections, but the role of IFITMs in shaping the enhanced antiviral immunity of reservoir bat species is unclear. Here, we identified an IFITM gene in Chinese rufous horseshoe bat, a natural host of severe acute respiratory syndrome (SARS)-related coronaviruses, that is alternatively spliced to produce two IFITM isoforms in native cells as shown by transcriptomics. These bat IFITMs have conserved structures in vitro as demonstrated by circular dichroism spectroscopy, yet they exhibit distinct antiviral specificities against influenza A virus, Nipah virus and coronaviruses including SARS-CoV, SARS-CoV-2 and MERS-CoV. In parallel with human IFITM1-3, bat IFITM isoforms localize to distinct sites of virus entry which influences their antiviral potency. Further bioinformatic analysis of IFITM repertoires in 206 mammals reveals that alternative splicing is a recurring strategy for IFITM diversification, albeit less widely adopted than gene duplication. These findings demonstrate that alternative splicing is a key strategy for evolutionary diversification in the IFITM family. Our study also highlights an example of convergent evolution where species-specific selection pressures led to expansion of the IFITM family through multiple means, underscoring the importance of IFITM diversity as a component of innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom.
- Deanery of Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.
- Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Haining, China.
- HIV Dynamics and Replication Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America.
- CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent and Greenwich Chatham Maritime, Kent, United Kingdom.
ORCID-Profile: Nelly S C Mak, Dan Zhang, Jordan Taylor, Aaron T Irving, Alex A Compton, Richard D Sloan
Förderung
- Medical Research Council
- University of Edinburgh and Leiden University Medical Center One Health PhD Studentship
- Natural Science Foundation of Zhejiang Province
- National Science Foundation Research Fund for International Excellent Young Scientists
Zitieren
APA
Mak, N. S. C., Liu, J., Zhang, D., Taylor, J., Li, X., Rahman, K., Chen, F., Datta, S. A. K., Lai, K. K., Shi, Z., Temperton, N., Irving, A. T., Compton, A. A., & Sloan, R. D. (2024). Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats. PLOS Pathogens, 20(12), e1012763. https://doi.org/10.1371/journal.ppat.1012763
Vancouver
Mak NSC, Liu J, Zhang D, Taylor J, Li X, Rahman K, et al. Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats. PLOS Pathogens. 2024;20(12):e1012763. doi:10.1371/journal.ppat.1012763
BibTeX
@article{Mak2024,
author = {Mak, Nelly S C and Liu, Jingyan and Zhang, Dan and Taylor, Jordan and Li, Xiaomeng and Rahman, Kazi and Chen, Feiyu and Datta, Siddhartha A K and Lai, Kin Kui and Shi, Zhengli and Temperton, Nigel and Irving, Aaron T and Compton, Alex A and Sloan, Richard D},
title = {Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats},
journal = {PLOS Pathogens},
year = {2024},
volume = {20},
number = {12},
pages = {e1012763},
doi = {10.1371/journal.ppat.1012763}
}
EUVIMED